Scott Flatt, MBA, is a seasoned sales professional with extensive experience in the pharmaceutical industry. Currently serving as an Institutional COVID-19 Specialty Representative at Gilead Sciences since January 2021, Flatt has a strong background that includes a role as Executive Institutional Representative for Antibacterials at Merck from March 2005 to March 2021. Flatt's earlier tenure at Cubist Pharmaceuticals, which merged with Merck in 2016, involved significant achievements, including multiple recognitions as the top performer in the country. Flatt has contributed to the development of reporting systems and marketing strategies to meet corporate goals. Flatt holds an MBA in Marketing from Morehead State University, graduating with a 3.75 GPA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices